Lupin announced the launch of Ipratropium Bromide Nasal Solution (Nasal Spray), 0.03% and 0.06%, in the United States. Ipratropium Bromide Nasal Solution (Nasal Spray), 0.03% and 0.06% are ...

Ipratropium bromide nasal solution (Nasal Spray) 0.03% is indicated for the symptomatic relief of rhinorrhea associated with ...

Lupin launches Ipratropium Bromide nasal spray in US, bioequivalent to Atrovent. The product addresses rhinitis and targets a $63 million market opportunity.

Lupin has announced the launch of Ipratropium Bromide Nasal Solution (nasal spray) in two strengths in the United States.

Lupin launches Ipratropium Bromide nasal spray for treating runny nose in the US market. Available in 0.03% and 0.06% ...

Mumbai: Global pharma major Lupin Limited has launched Ipratropium Bromide Nasal Solution (Nasal Spray), 0.03% and 0.06%, in ...

The Cigna Group CI recently announced that it will start covering RhinAer, a minimally invasive solution for chronic rhinitis ...

The Friedman curve, the gold standard for rates of cervical dilation and fetal descent during active labor, was developed almost 50 years ago.